申请人:GlaxoSmithKline Intellectual Property Development
Limited
公开号:EP3455220A1
公开(公告)日:2019-03-20
[EN] MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE<br/>[FR] MODULATEURS D'INDOLAMINE 2,3-DIOXYGÉNASE
申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2017195149A1
公开(公告)日:2017-11-16
Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.